nodes	percent_of_prediction	percent_of_DWPC	metapath
Drospirenone—NR3C2—nephron—focal segmental glomerulosclerosis	0.223	0.361	CbGeAlD
Drospirenone—PTGS2—nephron—focal segmental glomerulosclerosis	0.104	0.168	CbGeAlD
Drospirenone—PTGS2—endothelium—focal segmental glomerulosclerosis	0.0488	0.079	CbGeAlD
Drospirenone—NR3C2—nephron tubule—focal segmental glomerulosclerosis	0.0482	0.078	CbGeAlD
Drospirenone—NR3C2—ACE Inhibitor Pathway—AGTR2—focal segmental glomerulosclerosis	0.045	0.147	CbGpPWpGaD
Drospirenone—NR3C2—kidney—focal segmental glomerulosclerosis	0.0423	0.0685	CbGeAlD
Drospirenone—NR3C2—cortex of kidney—focal segmental glomerulosclerosis	0.0412	0.0667	CbGeAlD
Drospirenone—NR3C2—ACE Inhibitor Pathway—ACE—focal segmental glomerulosclerosis	0.0384	0.125	CbGpPWpGaD
Drospirenone—NR3C2—ACE Inhibitor Pathway—AGTR1—focal segmental glomerulosclerosis	0.0346	0.113	CbGpPWpGaD
Drospirenone—AR—kidney—focal segmental glomerulosclerosis	0.0313	0.0508	CbGeAlD
Drospirenone—AR—cortex of kidney—focal segmental glomerulosclerosis	0.0305	0.0494	CbGeAlD
Drospirenone—BCHE—nephron tubule—focal segmental glomerulosclerosis	0.029	0.047	CbGeAlD
Drospirenone—NR3C2—ACE Inhibitor Pathway—AGT—focal segmental glomerulosclerosis	0.0243	0.0794	CbGpPWpGaD
Drospirenone—PTGS2—kidney—focal segmental glomerulosclerosis	0.0197	0.0318	CbGeAlD
Drospirenone—PTGS2—Overview of nanoparticle effects—COL4A1—focal segmental glomerulosclerosis	0.0178	0.058	CbGpPWpGaD
Drospirenone—Uterine haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.0163	0.215	CcSEcCtD
Drospirenone—AR—Coregulation of Androgen receptor activity—PIAS1—focal segmental glomerulosclerosis	0.0132	0.0432	CbGpPWpGaD
Drospirenone—NR3C2—ACE Inhibitor Pathway—TGFB1—focal segmental glomerulosclerosis	0.0118	0.0386	CbGpPWpGaD
Drospirenone—AR—Androgen receptor signaling pathway—PIAS1—focal segmental glomerulosclerosis	0.00978	0.0319	CbGpPWpGaD
Drospirenone—Thrombosis—Cyclosporine—focal segmental glomerulosclerosis	0.00804	0.106	CcSEcCtD
Drospirenone—Breast pain—Cyclosporine—focal segmental glomerulosclerosis	0.00652	0.0859	CcSEcCtD
Drospirenone—AR—Integrated Breast Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.0064	0.0209	CbGpPWpGaD
Drospirenone—PGR—Validated nuclear estrogen receptor alpha network—PCNA—focal segmental glomerulosclerosis	0.00558	0.0182	CbGpPWpGaD
Drospirenone—PTGS2—Overview of nanoparticle effects—FN1—focal segmental glomerulosclerosis	0.00549	0.0179	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.00531	0.0173	CbGpPWpGaD
Drospirenone—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—focal segmental glomerulosclerosis	0.00504	0.0165	CbGpPWpGaD
Drospirenone—PTGS2—Prostaglandin Synthesis and Regulation—EDN1—focal segmental glomerulosclerosis	0.00497	0.0162	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—COL4A1—focal segmental glomerulosclerosis	0.00412	0.0135	CbGpPWpGaD
Drospirenone—BCHE—Peptide hormone metabolism—ACE—focal segmental glomerulosclerosis	0.00411	0.0134	CbGpPWpGaD
Drospirenone—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.00407	0.0536	CcSEcCtD
Drospirenone—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.00407	0.0536	CcSEcCtD
Drospirenone—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.00391	0.0515	CcSEcCtD
Drospirenone—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00373	0.0492	CcSEcCtD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	0.0035	0.0114	CbGpPWpGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—LPL—focal segmental glomerulosclerosis	0.00342	0.0112	CbGpPWpGaD
Drospirenone—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—focal segmental glomerulosclerosis	0.00333	0.0109	CbGpPWpGaD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—focal segmental glomerulosclerosis	0.00326	0.0106	CbGpPWpGaD
Drospirenone—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.00318	0.0418	CcSEcCtD
Drospirenone—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.00314	0.0413	CcSEcCtD
Drospirenone—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.00312	0.0411	CcSEcCtD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.00305	0.00996	CbGpPWpGaD
Drospirenone—NR3C2—Generic Transcription Pathway—CTGF—focal segmental glomerulosclerosis	0.00294	0.00961	CbGpPWpGaD
Drospirenone—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.00287	0.0378	CcSEcCtD
Drospirenone—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00286	0.0376	CcSEcCtD
Drospirenone—BCHE—Peptide hormone metabolism—AGT—focal segmental glomerulosclerosis	0.0026	0.0085	CbGpPWpGaD
Drospirenone—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00259	0.0342	CcSEcCtD
Drospirenone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—focal segmental glomerulosclerosis	0.00256	0.00837	CbGpPWpGaD
Drospirenone—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0025	0.033	CcSEcCtD
Drospirenone—AR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—focal segmental glomerulosclerosis	0.00249	0.00813	CbGpPWpGaD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.0021	0.0277	CcSEcCtD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	0.00201	0.00658	CbGpPWpGaD
Drospirenone—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00199	0.0262	CcSEcCtD
Drospirenone—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00197	0.026	CcSEcCtD
Drospirenone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—focal segmental glomerulosclerosis	0.00193	0.00629	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—CTGF—focal segmental glomerulosclerosis	0.00179	0.00585	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	0.00177	0.00578	CbGpPWpGaD
Drospirenone—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00175	0.0231	CcSEcCtD
Drospirenone—NR3C2—Gene Expression—CTGF—focal segmental glomerulosclerosis	0.00142	0.00463	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—CTGF—focal segmental glomerulosclerosis	0.00137	0.00446	CbGpPWpGaD
Drospirenone—NR3C2—Generic Transcription Pathway—SERPINE1—focal segmental glomerulosclerosis	0.00134	0.00438	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	0.00134	0.00437	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—ALB—focal segmental glomerulosclerosis	0.00134	0.00437	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—NOS2—focal segmental glomerulosclerosis	0.00126	0.00411	CbGpPWpGaD
Drospirenone—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00121	0.0159	CcSEcCtD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.00109	0.00356	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00108	0.00354	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	0.00102	0.00333	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000995	0.00325	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000959	0.00313	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—CTGF—focal segmental glomerulosclerosis	0.000863	0.00282	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000841	0.00275	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—SERPINE1—focal segmental glomerulosclerosis	0.000817	0.00267	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—MMP9—focal segmental glomerulosclerosis	0.000812	0.00265	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	0.000791	0.00258	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—ACE—focal segmental glomerulosclerosis	0.000775	0.00253	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.00075	0.00245	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—TGFB1—focal segmental glomerulosclerosis	0.000669	0.00218	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000665	0.00217	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.00066	0.00216	CbGpPWpGaD
Drospirenone—AR—Gene Expression—CTGF—focal segmental glomerulosclerosis	0.000658	0.00215	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—SERPINE1—focal segmental glomerulosclerosis	0.000646	0.00211	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—SERPINE1—focal segmental glomerulosclerosis	0.000623	0.00203	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000619	0.00202	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000615	0.00201	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000569	0.00186	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000517	0.00169	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—AGT—focal segmental glomerulosclerosis	0.000491	0.0016	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000485	0.00158	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000473	0.00154	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000458	0.00149	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	0.000455	0.00149	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.000436	0.00142	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000427	0.00139	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000401	0.00131	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000394	0.00128	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—SERPINE1—focal segmental glomerulosclerosis	0.000393	0.00128	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000391	0.00128	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000389	0.00127	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—MMP2—focal segmental glomerulosclerosis	0.000385	0.00126	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000368	0.0012	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000334	0.00109	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000333	0.00109	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000307	0.001	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.0003	0.000981	CbGpPWpGaD
Drospirenone—AR—Gene Expression—SERPINE1—focal segmental glomerulosclerosis	0.0003	0.000979	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—LPL—focal segmental glomerulosclerosis	0.000296	0.000967	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000294	0.00096	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000271	0.000884	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000256	0.000835	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—AGT—focal segmental glomerulosclerosis	0.000253	0.000827	CbGpPWpGaD
Drospirenone—PTGS2—Disease—LPL—focal segmental glomerulosclerosis	0.000243	0.000794	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—LPL—focal segmental glomerulosclerosis	0.000204	0.000665	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000196	0.00064	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ALB—focal segmental glomerulosclerosis	0.000194	0.000635	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NOS2—focal segmental glomerulosclerosis	0.00019	0.00062	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—AGT—focal segmental glomerulosclerosis	0.000174	0.000569	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000162	0.000527	CbGpPWpGaD
Drospirenone—PTGS2—Disease—SERPINE1—focal segmental glomerulosclerosis	0.00016	0.000523	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ALB—focal segmental glomerulosclerosis	0.000134	0.000437	CbGpPWpGaD
Drospirenone—PTGS2—Disease—TGFB1—focal segmental glomerulosclerosis	0.000101	0.00033	CbGpPWpGaD
Drospirenone—Norethindrone—ALB—focal segmental glomerulosclerosis	2.89e-05	0.4	CrCbGaD
Drospirenone—Methyltestosterone—ALB—focal segmental glomerulosclerosis	2.74e-05	0.38	CrCbGaD
Drospirenone—Testosterone—ALB—focal segmental glomerulosclerosis	1.59e-05	0.22	CrCbGaD
